Search research articles
Contact Us
Filters
Showing results (111-120 of 115) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 115 results.
JAMA Ophthalmology
|
May 26, 2017
Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma
Dana M Blumberg, Carlos Gustavo De Moraes, Alisa J Prager, et al.
JAMA Ophthalmology
|
June 9, 2017
Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life
Alisa J Prager, Donald C Hood, Jeffrey M Liebmann, et al.
Biomarkers in Medicine
|
November 26, 2013
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer
Alisa J Prager, Cynthia R Peng, Elena Lita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia
David P Steensma, Jeff A Sloan, Shaker R Dakhil, et al.
Neurobiology of Disease
|
August 25, 2014
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
R P Hulse, N Beazley-Long, J Hua, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 115) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 115 results.
JAMA Ophthalmology
|
May 26, 2017
Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma
Dana M Blumberg, Carlos Gustavo De Moraes, Alisa J Prager, et al.
JAMA Ophthalmology
|
June 9, 2017
Association of Glaucoma-Related, Optical Coherence Tomography-Measured Macular Damage With Vision-Related Quality of Life
Alisa J Prager, Donald C Hood, Jeffrey M Liebmann, et al.
Biomarkers in Medicine
|
November 26, 2013
Urinary aHGF, IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer
Alisa J Prager, Cynthia R Peng, Elena Lita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia
David P Steensma, Jeff A Sloan, Shaker R Dakhil, et al.
Neurobiology of Disease
|
August 25, 2014
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
R P Hulse, N Beazley-Long, J Hua, et al.
Page
of 12